新着情報

Lee & Ko Attorneys Keum Nang Park of the Healthcare Group have been named to Benchmark Litigation Asia-Pacific’s ‘Top 100 Women in Litigation 2026’ in recognition of their outstanding achievements in healthcare-related patent and regulatory disputes, as well as major competition law matters.

Ms. Park serves as Co-Head of Lee & Ko’s Healthcare Group, advising clients on intellectual property matters—including pharmaceutical and biotechnology patents—as well as a broad range of regulatory matters involving the Ministry of Health and Welfare, the Ministry of Food and Drug Safety, and the Ministry of Environment. She brings deep and wide-ranging expertise across the healthcare industry, including pharmaceuticals, medical devices, cosmetics, food, dietary supplements and household chemical products. Ms. Park was named to this year’s list in recognition of her success in defending market exclusivity on behalf of the patent holder of a world-renowned cardiovascular blockbuster drug, prevailing in more than 100 patent suits brought by numerous generic manufacturers. Her selection also reflects her achievements in protecting patent rights in litigation involving a widely used blockbuster biologic for chronic inflammatory disease and a prominent blockbuster biologic for ophthalmic disease.

Benchmark Litigation, published by Delinian, formerly Euromoney, is a globally renowned publication focusing on dispute resolution and litigation. Its annual ‘Top 100 Women in Litigation’ list recognizes 100 leading female litigators in the Asia-Pacific region based on months of in-depth research and analysis.

Lee&Ko法律事務所が「Benchmark Litigation Asia-Pacific 2022」の9分野において韓国1位（Tier 1）のローファームに選ばれました。また、Lee&Ko所属の弁護士23人が「Litigation Star」や「Future Star」に選ばれ、専門分野における成果を認められました。

Commercial and Transactions  Competition/Antitrust  Construction  Insolvency  Intellectual Property  International Arbitration  Labor and Employment  Product Liability and Recall  White Collar Crime 

Euromoneyが発行するBenchmark Litigationは、紛争調整および訴訟法分野における世界的専門誌であり、毎年ローファームからの提出資料や弁護士、クライアント、訴訟専門家らのインタビューを深層分析して順位を発表しています。